At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
mifepristone 200 mg +1 moredrug
Likely dose
mifepristone 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Mifepristone vs. Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
In Brief
A clinical study evaluating mifepristone 200 mg and osmotic dilator insertion for Abortion. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Women who are requesting pregnancy termination at 14-16 weeks, who would normally have osmotic dilator insertion the day before their procedure, would be asked if they wanted to participate. Participants would be randomized to two groups: first, dilator insertion as usual, or second, mifepristone taken the day before the procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbortion
CountriesUnited States
CollaboratorsSociety of Family Planning
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2009
Enrollment StartOct 2009
Primary CompletionMar 2011
TodayJul 2026
First PostedSep 30, 2009
Enrollment StartOct 1, 2009
Primary CompletionMar 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 16.8 years ago
Interventions
mifepristone 200 mgdrug
mifepristone would be given the day before the procedure
osmotic dilator insertiondevice
osmotic dilators (3-6) would be inserted as usual the day before the procedure